Skip to main content

Increasing IVF success rate through the first magnetic resonance system for embryonic quantitative analysis at the cell scale

Project description

Nuclear magnetic resonance makes a mark on fertility treatment

The success of in vitro fertilisation largely relies on selecting the embryo with the highest likelihood of developing into a healthy baby. This remains a challenge for doctors, who count on insufficient or costly methods such as microscope examination or biopsy, respectively. With a small percentage of IVF attempts resulting in a successful pregnancy, there is a need for superior screening options. Supported by the EU-funded Embryospin project, Annaida Technologies have developed a novel solution for fast and non-invasive embryo screening: a ground-breaking device that performs microscopic nuclear magnetic resonance at a scale 10 times better than existing technologies and can provide results for up to 10 embryos in one hour. The technique is set to increase the success of the fertility treatment while also cutting costs for the couples undergoing IVF.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Coordinator

ANNAIDA TECHNOLOGIES SA
Net EU contribution
€ 50 000,00
Address
Avenue Louis-ruchonnet 26
1003 Lausanne
Switzerland

See on map

Region
Schweiz/Suisse/Svizzera Région lémanique Vaud
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 21 429,00